Windtree Therapeutics Inc (WINT): Cash & Equivalents

Annual figures by period end, from SEC filings.

Not updated since 2024-12-31. No annual report in US GAAP has been filed since. Companies that switch to IFRS reporting, as many foreign filers do, or stop filing are not updated here.

$1.78M
As of 2024-12-31
$204.0K
As of 2025-09-30
-57.0%
3-year compound annual growth
-39.8%
5-year compound annual growth
-27.6%
10-year compound annual growth
$86.28M2010-12-31: $10.21M2011-12-31: $10.19M2012-12-31: $26.89M2013-12-31: $86.28M2014-12-31: $44.71M2015-12-31: $38.72M2016-12-31: $5.59M2017-12-31: $1.81M2018-12-31: $11.19M2019-12-31: $22.58M2020-12-31: $16.93M2021-12-31: $22.35M2022-12-31: $6.17M2023-12-31: $4.32M2024-12-31: $1.78M$1.78M
2010-12-31 Cash & Equivalents (USD) 2024-12-31
Period endedCash & EquivalentsChange YoYSource filing
2024-12-31$1.78M-58.8%2025-04-15, Balance as of period end
2023-12-31$4.32M-30.0%2025-04-15, Balance as of period end
2022-12-31$6.17M-72.4%2024-04-16, Balance as of period end
2021-12-31$22.35M+32.0%2023-03-31, Balance as of period end
2020-12-31$16.93M-25.0%2022-03-31, Balance as of period end
2019-12-31$22.58M+101.8%2021-03-29, Balance as of period end
2018-12-31$11.19M+516.4%2020-04-03, Balance as of period end
2017-12-31$1.81M-67.5%2019-04-23, Balance as of period end
2016-12-31$5.59M-85.6%2018-04-17, Balance as of period end
2015-12-31$38.72M-13.4%2017-03-31, Balance as of period end
2014-12-31$44.71M-48.2%2016-03-29, Balance as of period end
2013-12-31$86.28M+220.9%2015-03-16, Balance as of period end
2012-12-31$26.89M+163.9%2015-03-16, Balance as of period end
2011-12-31$10.19M-0.2%2014-03-17, Balance as of period end
2010-12-31$10.21Mn/a2013-03-15, Balance as of period end